Thyroid hormone signaling in vivo requires a balance between coactivators and corepressors

Molecular and Cellular Biology

Volumn 34, Issue 9, 2014, Pages 1564-1575

  Vella, Kristen R ^a   Ramadoss, Preeti ^a   Costa e Sousa, Ricardo H ^a,b   Astapova, Inna ^a   Ye, Felix D ^a   Holtz, Kaila A ^a   Harris, Jamie C ^a   Hollenberg, Anthony N ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; NUCLEAR RECEPTOR COACTIVATOR; NUCLEAR RECEPTOR COACTIVATOR 2; NUCLEAR RECEPTOR COREPRESSOR; RECEPTOR INTERACTING PROTEIN 140; STEROID RECEPTOR COACTIVATOR 1; THYROID HORMONE; THYROID HORMONE RECEPTOR BETA; THYROTROPIN; TRIIODOTHYRONINE DERIVATIVE;

ALLELE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; CELL INTERACTION; CELL TYPE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; FEMALE; GENE ACTIVATION; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; GENETIC DIFFERENCE; HORMONE SENSITIVITY; HYPOPHYSIS; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; SIGNAL TRANSDUCTION; THYROID FUNCTION;

ANIMALS; CO-REPRESSOR PROTEINS; FEMALE; GENE DELETION; HUMANS; MALE; MICE; MUTATION; NUCLEAR RECEPTOR COACTIVATOR 1; NUCLEAR RECEPTOR COACTIVATOR 2; PITUITARY GLAND; SIGNAL TRANSDUCTION; THYROID HORMONE RECEPTORS BETA; THYROID HORMONE RESISTANCE SYNDROME; THYROID HORMONES; THYROTROPIN; TRIIODOTHYRONINE;

EID: 84897547500     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00129-14     Document Type: Article

References (57)

1. Costa-e-Sousa RH, Hollenberg AN. 2012. Minireview: the neural regulation of the hypothalamic-pituitary-thyroid axis. Endocrinology 153: 4128-4135. http://dx.doi.org/10.1210/en.2012-1467.
2. Chiamolera MI, Wondisford FE. 2009. Minireview: thyrotropinreleasing hormone and the thyroid hormone feedback mechanism. Endocrinology 150:1091-1096. http://dx.doi.org/10.1210/en.2008-1795.
3. Zhang J, Lazar MA. 2000. The mechanism of action of thyroid hormones. Annu. Rev. Physiol. 62:439-466. http://dx.doi.org/10.1146/annurev.physiol.62.1.439.
4. Yen PM. 2001. Physiological and molecular basis of thyroid hormone action. Physiol. Rev. 81:1097-1142.
5. Cheng SY, Leonard JL, Davis PJ. 2010. Molecular aspects of thyroid hormone actions. Endocr. Rev. 31:139-170. http://dx.doi.org/10.1210/er.2009-0007.
6. Onate SA, Tsai SY, Tsai MJ, O'Malley BW. 1995. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354-1357. http://dx.doi.org/10.1126/science.270.5240.1354.
7. McKenna NJ, Lanz RB, O'Malley BW. 1999. Nuclear receptor coregulators: cellular and molecular biology. Endocr. Rev. 20:321-344. http://dx.doi.org/10.1210/edrv.20.3.0366.
8. McKenna NJ, O'Malley BW. 2002. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108:465-474. http://dx.doi.org/10.1016/S0092-8674(02)00641-4.
9. Leo C, Chen JD. 2000. The SRC family of nuclear receptor coactivators. Gene 245:1-11. http://dx.doi.org/10.1016/S0378-1119(00)00024-X.
10. Hermanson O, Glass CK, Rosenfeld MG. 2002. Nuclear receptor coregulators: multiple modes of modification. Trends Endocrinol. Metab. 13:55-60. http://dx.doi.org/10.1016/S1043-2760(01)00527-6.
11. McInerney EM, Rose DW, Flynn SE, Westin S, Mullen TM, Krones A, Inostroza J, Torchia J, Nolte RT, Assa-Munt N, Milburn MV, Glass CK, Rosenfeld MG. 1998. Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation. Genes Dev. 12:3357-3368. http://dx.doi.org/10.1101/gad.12.21.3357.
12. Xu J, Li Q. 2003. Review of the in vivo functions of the p160 steroid receptor coactivator family. Mol. Endocrinol. 17:1681-1692. http://dx.doi.org/10.1210/me.2003-0116.
13. Horlein AJ, Naar AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Soderstrom M, Glass CK, Rosenfeld MG. 1995. Ligandindependent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377:397-404. http://dx.doi.org/10.1038/377397a0.
14. Alland L, Muhle R, Hou H, Jr, Potes J, Chin L, Schreiber-Agus N, DePinho RA. 1997. Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature 387:49-55. http://dx.doi.org/10.1038/387049a0.
15. Guenther MG, Barak O, Lazar MA. 2001. The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3. Mol. Cell. Biol. 21:6091-6101. http://dx.doi.org/10.1128/MCB.21.18.6091-6101.2001.
16. Heinzel T, Lavinsky RM, Mullen TM, Soderstrom M, Laherty CD, Torchia J, Yang WM, Brard G, Ngo SD, Davie JR, Seto E, Eisenman RN, Rose DW, Glass CK, Rosenfeld MG. 1997. A complex containing NCoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387:43-48. http://dx.doi.org/10.1038/387043a0.
17. Nagy L, Kao HY, Chakravarti D, Lin RJ, Hassig CA, Ayer DE, Schreiber SL, Evans RM. 1997. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89:373-380. http://dx.doi.org/10.1016/S0092-8674(00)80218-4.
18. Perissi V, Jepsen K, Glass CK, Rosenfeld MG. 2010. Deconstructing repression: evolving models of co-repressor action. Nat. Rev. Genet. 11: 109-123. http://dx.doi.org/10.1038/nrg2736.
19. Fang S, Suh JM, Atkins AR, Hong SH, Leblanc M, Nofsinger RR, Yu RT, Downes M, Evans RM. 2011. Corepressor SMRT promotes oxidative phosphorylation in adipose tissue and protects against diet-induced obesity and insulin resistance. Proc. Natl. Acad. Sci. U. S. A. 108:3412-3417. http://dx.doi.org/10.1073/pnas.1017707108.
20. Weiss RE, Xu J, Ning G, Pohlenz J, O'Malley BW, Refetoff S. 1999. Mice deficient in the steroid receptor co-activator 1 (SRC-1) are resistant to thyroid hormone. EMBO J. 18:1900-1904. http://dx.doi.org/10.1093/emboj/18.7.1900.
21. Ortiga-Carvalho TM, Shibusawa N, Nikrodhanond A, Oliveira KJ, Machado DS, Liao XH, Cohen RN, Refetoff S, Wondisford FE. 2005. Negative regulation by thyroid hormone receptor requires an intact coactivator-binding surface. J. Clin. Invest. 115:2517-2523. http://dx.doi.org/10.1172/JCI24109.
22. Pei L, Leblanc M, Barish G, Atkins A, Nofsinger R, Whyte J, Gold D, He M, Kawamura K, Li HR, Downes M, Yu RT, Powell HC, Lingrel JB, Evans RM. 2011. Thyroid hormone receptor repression is linked to type I pneumocyte-associated respiratory distress syndrome. Nat. Med. 17: 1466-1472. http://dx.doi.org/10.1038/nm.2450.
23. Astapova I, Lee LJ, Morales C, Tauber S, Bilban M, Hollenberg AN. 2008. The nuclear corepressor, NCoR, regulates thyroid hormone action in vivo. Proc. Natl. Acad. Sci. U. S. A. 105:19544-19549. http://dx.doi.org/10.1073/pnas.0804604105.
24. Astapova I, Vella KR, Ramadoss P, Holtz KA, Rodwin BA, Liao XH, Weiss RE, Rosenberg MA, Rosenzweig A, Hollenberg AN. 2011. The nuclear receptor corepressor (NCoR) controls thyroid hormone sensitivity and the set point of the hypothalamic-pituitary-thyroid axis. Mol. Endocrinol. 25:212-224. http://dx.doi.org/10.1210/me.2010-0462.
25. Costa-e-Sousa RH, Astapova I, Ye F, Wondisford FE, Hollenberg AN. 2012. The thyroid axis is regulated by NCoR1 via its actions in the pituitary. Endocrinology 153:5049-5057. http://dx.doi.org/10.1210/en.2012-1504.
26. Jonas BA, Varlakhanova N, Hayakawa F, Goodson M, Privalsky ML. 2007. Response of SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) and N-CoR (nuclear receptor corepressor) corepressors to mitogen-activated protein kinase kinase kinase cascades is determined by alternative mRNA splicing. Mol. Endocrinol. 21:1924-1939. http://dx.doi.org/10.1210/me.2007-0035.
27. Makowski A, Brzostek S, Cohen RN, Hollenberg AN. 2003. Determination of nuclear receptor corepressor interactions with the thyroid hormone receptor. Mol. Endocrinol. 17:273-286. http://dx.doi.org/10.1210/me.2002-0310.
28. Astapova I, Dordek MF, Hollenberg AN. 2009. The thyroid hormone receptor recruits NCoR via widely spaced receptor-interacting domains. Mol. Cell. Endocrinol. 307:83-88. http://dx.doi.org/10.1016/j.mce.2009.02.028.
29. Zamir I, Zhang J, Lazar MA. 1997. Stoichiometric and steric principles governing repression by nuclear hormone receptors. Genes Dev. 11:835-846. http://dx.doi.org/10.1101/gad.11.7.835.
30. Webb P, Anderson CM, Valentine C, Nguyen P, Marimuthu A, West BL, Baxter JD, Kushner PJ. 2000. The nuclear receptor corepressor (N-CoR) contains three isoleucine motifs (I/LXXII) that serve as receptor interaction domains (IDs). Mol. Endocrinol. 14:1976-1985. http://dx.doi.org/10.1210/me.14.12.1976.
31. Cohen RN, Brzostek S, Kim B, Chorev M, Wondisford FE, Hollenberg AN. 2001. The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains. Mol. Endocrinol. 15:1049-1061. http://dx.doi.org/10.1210/me.15.7.1049.
32. Cohen RN, Putney A, Wondisford FE, Hollenberg AN. 2000. The nuclear corepressors recognize distinct nuclear receptor complexes. Mol. Endocrinol. 14:900-914. http://dx.doi.org/10.1210/me.14.6.900.
33. Alenghat T, Meyers K, Mullican SE, Leitner K, Adeniji-Adele A, Avila J, Bucan M, Ahima RS, Kaestner KH, Lazar MA. 2008. Nuclear receptor corepressor and histone deacetylase 3 govern circadian metabolic physiology. Nature 456:997-1000. http://dx.doi.org/10.1038/nature07541.
34. You SH, Liao X, Weiss RE, Lazar MA. 2010. The interaction between nuclear receptor corepressor and histone deacetylase 3 regulates both positive and negative thyroid hormone action in vivo. Mol. Endocrinol. 24: 1359-1367. http://dx.doi.org/10.1210/me.2009-0501.
35. Refetoff S, Weiss RE, Usala SJ. 1993. The syndromes of resistance to thyroid hormone. Endocr. Rev. 14:348-399. http://dx.doi.org/10.1210/edrv-14-3-348.
36. Weiss RE, Tunca H, Knapple WL, Faas FH, Refetoff S. 1997. Phenotype differences of resistance to thyroid hormone in two unrelated families with an identical mutation in the thyroid hormone receptor beta gene (R320C). Thyroid 7:35-38. http://dx.doi.org/10.1089/thy.1997.7.35.
37. Parrilla R, Mixson AJ, McPherson JA, McClaskey JH, Weintraub BD. 1991. Characterization of seven novel mutations of the c-erbA beta gene in unrelated kindreds with generalized thyroid hormone resistance. Evidence for two "hot spot" regions of the ligand binding domain. J. Clin. Invest. 88:2123-2130.
38. Kaneshige M, Kaneshige K, Zhu X, Dace A, Garrett L, Carter TA, Kazlauskaite R, Pankratz DG, Wynshaw-Boris A, Refetoff S, Weintraub B, Willingham MC, Barlow C, Cheng S. 2000. Mice with a targeted mutation in the thyroid hormone beta receptor gene exhibit impaired growth and resistance to thyroid hormone. Proc. Natl. Acad. Sci. U. S. A. 97:13209-13214. http://dx.doi.org/10.1073/pnas.230285997.
39. Mitchell CS, Savage DB, Dufour S, Schoenmakers N, Murgatroyd P, Befroy D, Halsall D, Northcott S, Raymond-Barker P, Curran S, Henning E, Keogh J, Owen P, Lazarus J, Rothman DL, Farooqi IS, Shulman GI, Chatterjee K, Petersen KF. 2010. Resistance to thyroid hormone is associated with raised energy expenditure, muscle mitochondrial uncoupling, and hyperphagia. J. Clin. Invest. 120:1345-1354. http://dx.doi.org/10.1172/JCI38793.
40. Fozzatti L, Lu C, Kim DW, Park JW, Astapova I, Gavrilova O, Willingham MC, Hollenberg AN, Cheng SY. 2011. Resistance to thyroid hormone is modulated in vivo by the nuclear receptor corepressor (NCOR1). Proc. Natl. Acad. Sci. U. S. A. 108:17462-17467. http://dx.doi.org/10.1073/pnas.1107474108.
41. Bottcher Y, Paufler T, Stehr T, Bertschat FL, Paschke R, Koch CA. 2007. Thyroid hormone resistance without mutations in thyroid hormone receptor beta. Med. Sci. Monit. 13:CS67-CS70.
42. Xu J, Qiu Y, DeMayo FJ, Tsai SY, Tsai MJ, O'Malley BW. 1998. Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene. Science 279:1922-1925. http://dx.doi.org/10.1126/science.279.5358.1922.
43. Nikrodhanond AA, Ortiga-Carvalho TM, Shibusawa N, Hashimoto K, Liao XH, Refetoff S, Yamada M, Mori M, Wondisford FE. 2006. Dominant role of thyrotropin-releasing hormone in the hypothalamicpituitary-thyroid axis. J. Biol. Chem. 281:5000-5007. http://dx.doi.org/10.1074/jbc.M511530200.
44. Castinetti F, Brinkmeier ML, Gordon DF, Vella KR, Kerr JM, Mortensen AH, Hollenberg A, Brue T, Ridgway EC, Camper SA. 2011. PITX2 and PITX1 regulate thyrotroph function and response to hypothyroidism. Mol. Endocrinol. 25:1950-1960. http://dx.doi.org/10.1210/me.2010-0388.
45. Vella KR, Ramadoss P, Lam FS, Harris JC, Ye FD, Same PD, O'Neill NF, Maratos-Flier E, Hollenberg AN. 2011. NPY and MC4R signaling regulate thyroid hormone levels during fasting through both central and peripheral pathways. Cell Metab. 14:780-790. http://dx.doi.org/10.1016/j.cmet.2011.10.009.
46. Ramadoss P, Unger-Smith NE, Lam FS, Hollenberg AN. 2009. STAT3 targets the regulatory regions of gluconeogenic genes in vivo. Mol. Endocrinol. 23:827-837. http://dx.doi.org/10.1210/me.2008-0264.
47. Ramadoss P, Abraham BJ, Tsai L, Zhou Y, Costa-e-Sousa RH, Ye F, Bilban M, Zhao K, Hollenberg AN. 2014. Novel mechanism of positive versus negative regulation by thyroid hormone receptor beta 1 (TRbeta1) identified by genome-wide profiling of binding sites in mouse liver. J. Biol. Chem. 289:1313-1328. http://dx.doi.org/10.1074/jbc.M113.521450.
48. Sadow PM, Chassande O, Gauthier K, Samarut J, Xu J, O'Malley BW, Weiss RE. 2003. Specificity of thyroid hormone receptor subtype and steroid receptor coactivator-1 on thyroid hormone action. Am. J. Physiol. Endocrinol. Metab. 284:E36-E46.
49. Alonso M, Goodwin C, Liao X, Ortiga-Carvalho T, Machado DS, Wondisford FE, Refetoff S, Weiss RE. 2009. In vivo interaction of steroid receptor coactivator (SRC)-1 and the activation function-2 domain of the thyroid hormone receptor (TR) beta in TRbeta E457A knock-in and SRC-1 knockout mice. Endocrinology 150:3927-3934. http://dx.doi.org/10.1210/en.2009-0093.
50. Kamiya Y, Zhang XY, Ying H, Kato Y, Willingham MC, Xu J, O'Malley BW, Cheng SY. 2003. Modulation by steroid receptor coactivator-1 of target-tissue responsiveness in resistance to thyroid hormone. Endocrinology 144:4144-4153. http://dx.doi.org/10.1210/en.2003-0239.
51. Sadow PM, Koo E, Chassande O, Gauthier K, Samarut J, Xu J, O'Malley BW, Seo H, Murata Y, Weiss RE. 2003. Thyroid hormone receptorspecific interactions with steroid receptor coactivator-1 in the pituitary. Mol. Endocrinol. 17:882-894. http://dx.doi.org/10.1210/me.2002-0174.
52. Takeuchi Y, Murata Y, Sadow P, Hayashi Y, Seo H, Xu J, O'Malley BW, Weiss RE, Refetoff S. 2002. Steroid receptor coactivator-1 deficiency causes variable alterations in the modulation of T(3)-regulated transcription of genes in vivo. Endocrinology 143:1346-1352. http://dx.doi.org/10.1210/en.143.4.1346.
53. Weiss RE, Gehin M, Xu J, Sadow PM, O'Malley BW, Chambon P, Refetoff S. 2002. Thyroid function in mice with compound heterozygous and homozygous disruptions of SRC-1 and TIF-2 coactivators: evidence for haploinsufficiency. Endocrinology 143:1554-1557. http://dx.doi.org/10.1210/en.143.4.1554.
54. Chopra AR, Kommagani R, Saha P, Louet JF, Salazar C, Song J, Jeong J, Finegold M, Viollet B, DeMayo F, Chan L, Moore DD, O'Malley BW. 2011. Cellular energy depletion resets whole-body energy by promoting coactivator-mediated dietary fuel absorption. Cell Metab. 13:35-43. http://dx.doi.org/10.1016/j.cmet.2010.12.001.
55. Yamada M, Saga Y, Shibusawa N, Hirato J, Murakami M, Iwasaki T, Hashimoto K, Satoh T, Wakabayashi K, Taketo MM, Mori M. 1997. Tertiary hypothyroidism and hyperglycemia in mice with targeted disruption of the thyrotropin-releasing hormone gene. Proc. Natl. Acad. Sci. U. S. A. 94:10862-10867. http://dx.doi.org/10.1073/pnas.94.20.10862.
56. Jeong JW, Kwak I, Lee KY, White LD, Wang XP, Brunicardi FC, O'Malley BW, DeMayo FJ. 2006. The genomic analysis of the impact of steroid receptor coactivators ablation on hepatic metabolism. Mol. Endocrinol. 20:1138-1152. http://dx.doi.org/10.1210/me.2005-0407.
57. Hollenberg AN. 2012. Metabolic health and nuclear-receptor sensitivity. N. Engl. J. Med. 366:1345-1347. http://dx.doi.org/10.1056/NEJMcibr 1114529.